Artelo Biosciences announces reverse stock split

• Artelo Biosciences (NASDAQ:ARTL) said on Wednesday that its board has approved a 6-for-1 reverse stock split of the company’s common stock.
• The company’s common shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market commencing at the